675 related articles for article (PubMed ID: 24907681)
21. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts.
Porta GD; Campardelli R; Falco N; Reverchon E
J Pharm Sci; 2011 Oct; 100(10):4357-67. PubMed ID: 21638283
[TBL] [Abstract][Full Text] [Related]
22. Practically feasible production of sustained-release microspheres of granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
Wu F; Dai L; Geng L; Zhu H; Jin T
J Control Release; 2017 Aug; 259():195-202. PubMed ID: 28389408
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.
Capan Y; Jiang G; Giovagnoli S; Na KH; DeLuca PP
AAPS PharmSciTech; 2003; 4(2):E28. PubMed ID: 12916910
[TBL] [Abstract][Full Text] [Related]
24. [Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique].
Zhou XL; He JT; Zhou ZT; Ma SF; Jiang Y; Wang Y
Yao Xue Xue Bao; 2010 Aug; 45(8):1057-63. PubMed ID: 21351596
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
27. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
Ahmed AR; Bodmeier R
Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
[TBL] [Abstract][Full Text] [Related]
28. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
29. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in rats.
Rong X; Mo X; Ren T; Yang S; Yuan W; Dong J; Wang Y; Wang X
Eur J Pharm Sci; 2011 Jul; 43(4):334-42. PubMed ID: 21621611
[TBL] [Abstract][Full Text] [Related]
31. Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.
Kakizawa Y; Nishio R; Hirano T; Koshi Y; Nukiwa M; Koiwa M; Michizoe J; Ida N
J Control Release; 2010 Feb; 142(1):8-13. PubMed ID: 19804802
[TBL] [Abstract][Full Text] [Related]
32. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
[TBL] [Abstract][Full Text] [Related]
33. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
[TBL] [Abstract][Full Text] [Related]
34. Sustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy.
Chang LC; Yang CY; Chua AC; Lin YJ; Lai SM
Mol Pharm; 2011 Oct; 8(5):1767-74. PubMed ID: 21842870
[TBL] [Abstract][Full Text] [Related]
35. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
[TBL] [Abstract][Full Text] [Related]
36. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
Pagar KP; Vavia PR
Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
[TBL] [Abstract][Full Text] [Related]
37. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
38. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres.
Yang TH; Dong A; Meyer J; Johnson OL; Cleland JL; Carpenter JF
J Pharm Sci; 1999 Feb; 88(2):161-5. PubMed ID: 9950632
[TBL] [Abstract][Full Text] [Related]
39. The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats.
Zhang ZX; Liu YK; Pan H; Pan L; Zhang Q; Su HM; Zhao QL; Li H; He C
Growth Horm IGF Res; 2012 Feb; 22(1):30-5. PubMed ID: 22257554
[TBL] [Abstract][Full Text] [Related]
40. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
